The diagnosis of Burkitt lymphoma: how do pathologists apply criteria in daily practice?-Reference-Cited by-同舟云学术

The diagnosis of Burkitt lymphoma: how do pathologists apply criteria in daily practice?

Published:2024-08-29 Issue: Volume: Page:1-4
ISSN:1042-8194
Container-title:Leukemia & Lymphoma
language:en
Short-container-title:Leukemia & Lymphoma

Author:

Brand Michiel van den¹²,Tzankov Alexandar³,Scheijde-Vermeulen Marijn⁴,Barbé Ellis⁵,Dirnhofer Stefan³,Stenner Frank⁶,Hebeda Konnie¹,Chamuleau Martine⁷,Jong Daphne de⁵

Affiliation:

1. Department of Pathology, Radboud University Medical Center, Nijmegen, the Netherlands

2. Pathology-DNA, location Rijnstate Hospital, Arnhem, the Netherlands

3. Institute of Medical Genetics and Pathology, University Hospital Basel, University of Basel, Basel, Switzerland

4. Department of Pathology, Princess Máxima Center for Paediatric Oncology, Utrecht, the Netherlands

5. Department of Pathology, AmsterdamUMC, location VU University Medical Center, Amsterdam, the Netherlands

6. Department of Oncology, University Hospital Basel, University of Basel, Basel, Switzerland

7. Department of Haematology, AmsterdamUMC, location VU University Medical Center, Amsterdam, the Netherlands

Publisher

Informa UK Limited

Link

https://www.tandfonline.com/doi/pdf/10.1080/10428194.2024.2396542

Reference15 articles.

1. WHO classification of tumours of haematopoietic and lymphoid tissues. Revised 4th edition ed. Lyon: International Agency for Research on Cancer; 2017.

2. The genetic landscape of mutations in Burkitt lymphoma

3. Recurrent mutation of the ID3 gene in Burkitt lymphoma identified by integrated genome, exome and transcriptome sequencing

4. Epstein–Barr virus positivity as a defining pathogenetic feature of Burkitt lymphoma subtypes

5. Swerdlow SH, Campo E, Harris NL, et al. WHO classification of tumours of haematopoietic and lymphoid tissues. Lyon (France): International Agency for Research on Cancer; 2008.